Correlation of High Sensitive C-Reactive Protein with the Extent of Coronary Atherosclerotic Disease


  • Saud Sherwan Anwer MB.Ch.B, MSc cardiology, High diploma candidate in interventional cardiology, College of Medicine, Hawler Medical University
  • Nasih Abdulah Gardi Iraqi Board in Internal Medicine, I.B.M.S-med, Msc interventional cardiology, Hawler Medical University



Atherosclerosis, High sensitive C-Reactive protein, Ischemic Heart disease


Background and objectives: The inflammatory process of the intima of coronary vessels is significant in the atherosclerotic process. We aimed to evaluate the role of high sensitive C-reactive protein in diagnosing and prognosis of ischemic heart disease and atherosclerosis.

Methods: From 2021-2022, we randomly enrolled 100 patients referred to surgical specialty hospital/ cardiac center in Erbil City (Jan 2021- Jan 2022) for angiography complaining of a chronic coronary syndrome. Blood sampling was taken to measure (high sensitive C-reactive protein). Coronary artery angiography was done, and the extent of atherosclerosis was measured using the Syntax score and clinical syntax score using the calculator from internet site

Results: We enrolled 58 males and 42 females; 39% of patients had Diabetes mellitus, 49% had hypertension, 41% were smoker, 18% with peripheral arterial disease, 8% had chronic obstructive disease, and 3% with left primary illness. The study showed a highly significant linear correlation between high sensitive C-reactive protein and syntax score of 15±10.52 and clinical syntax score 26.68±12.17. 

Conclusion: The study concluded that a high sensitive  C-reactive protein level is a reliable method to independently predict coronary artery disease in ischemic heart disease patients and the extent of severity; these results were not affected by sex category and other risk factors like diabetes mellitus, hypertension, or smoking.



Download data is not yet available.


Roth GA, Mensah GA, Johnson CO, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021.

Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2020 14; 41(3):407–77.

Black S, Kushner I SD. C-reactive protein. J Biol Chem. 2004; 2(279):48487–90.

Ridker PM, Buring JE, Rifai N, et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007; 297(6):611–9.

Ballou SP, Kushner I. C-reactive protein and the acute phase response. Adv Intern Med. 1992;37: 313–36.

. Kushner I, Kaplan MH. Studies of acute phase protein. I. An immunohistochemical method for the localization of Cx-reactive protein in rabbits. Association with necrosis in local inflammatory lesions. J Exp Med. 1961; 114(6):961–74.

Zahedi K, Mortensen RF. Macrophage tumoricidal activity induced by human C-reactive protein. Cancer Res. 1986; 46(10):5077–83.

Barna BP, Thomassen MJ CM. Cytoquine induction associated with human C-reactive protein. Fed Am Soc Exp Biol J. 1989; 4(3):284.

Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360(10):961–72.

Yildiz A, Kaya Z. Uric acid: a crucial marker of cardiovascular diseases? Int J Cardiol. 2012; 159(2): 158

Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16(1):31–41.

Habib SS, Al Masri A. Relationship of high sensitivity C-reactive protein with presence and severity of coronary artery disease. Pakistan J Med Sci. 2013;29(6):1425–9.

Ozdemir B. Correlation of C-Reactive Protein and Serum Iron Levels with Syntax Score. Arch Razi Inst. 2020;75(3):413–8.

Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 2009;5(1):50-6.

van Gaal WJ, Ponnuthurai FA, Selvanayagam J, et al. The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention. Int J Cardiol. 2009; 135(1):60–5.

Garg S, Sarno G, Garcia-Garcia HM, et al. A new tool for the risk stratification of patients with complex coronary artery disease the clinical SYNTAX score. Circ Cardiovasc Interv. 2010; 3 (4):317–26.

Drakopoulou M, Toutouzas K, Stefanadi E, et al. Association of inflammatory markers with angiographic severity and extent of coronary artery disease. Atherosclerosis. 2009; 206(2):335–9.

Koenig W. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy. Int J Cardiol. 2013; 168(6):5126–34.

Liu Y, Jia S, Yao Y, et al. Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention. J Cardiol. 2020; 75(1):60–5.

Al Aseri ZA, Habib SS, Marzouk A. Predictive value of high sensitivity C-reactive protein on progression to heart failure occurring after the first myocardial infarction. Vasc Health Risk Manag. 2019; 15:221–7.

Chiriboga DE, Ma Y, Li W, et al. Seasonal and sex variation of high-sensitivity C-reactive protein in healthy adults: a longitudinal study. Clin Chem. 2009; 55(2):313–21.

Musunuru K, Kral BG, Blumenthal RS, et al. The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med. 2008;5(10):621–35.




How to Cite

Anwer, S. S. ., & Gardi, . N. A. . (2024). Correlation of High Sensitive C-Reactive Protein with the Extent of Coronary Atherosclerotic Disease. AMJ (Advanced Medical Journal) , 9(1), 167-174.